The Wall Street Journal
China’s Innovent Strikes Cancer Drug Deal With Takeda for Up to $11.4 Billion — The tie-up is the latest between Chinese companies and international pharma majors looking to expand their global reach and tap promising drug pipelines developing in China.
The U.S. Is Trying to Drive a Wedge Between Argentina and China — The South American country is relying on the U.S. and Wall Street banks for a bailout.
Opinion: China’s Big London Spy Platform — Beij
Subscribe or login to read the rest.
Subscribers get full access to:
- Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
- A weekly curated reading list on China from Andrew Peaple.
- A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our
Subscriptions page for details.
Includes images from Depositphotos.com
